Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
23401 | 292 | 21.9 | 40% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
662 | 12640 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OHMEFENTANYL | Author keyword | 7 | 53% | 3% | 9 |
2 | FENTANYL ANALOGS | Author keyword | 5 | 63% | 2% | 5 |
3 | 4 ANILIDOPIPERIDINES | Author keyword | 2 | 67% | 1% | 2 |
4 | MM2 87 | Author keyword | 2 | 67% | 1% | 2 |
5 | USTAV OCHRANY PROTI ZBRANIM HROMADNEHO NICENI | Address | 2 | 67% | 1% | 2 |
6 | LIGAND MODEL | Author keyword | 1 | 100% | 1% | 2 |
7 | OPIOID LIGAND MODEL | Author keyword | 1 | 100% | 1% | 2 |
8 | 3D STRUCTURE ACTIVITY RELATIONSHIP | Author keyword | 1 | 50% | 0% | 1 |
9 | CONFORMATIONAL PROFILE | Author keyword | 1 | 50% | 0% | 1 |
10 | DIAZABICYCLOOCTANE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OHMEFENTANYL | 7 | 53% | 3% | 9 | Search OHMEFENTANYL | Search OHMEFENTANYL |
2 | FENTANYL ANALOGS | 5 | 63% | 2% | 5 | Search FENTANYL+ANALOGS | Search FENTANYL+ANALOGS |
3 | 4 ANILIDOPIPERIDINES | 2 | 67% | 1% | 2 | Search 4+ANILIDOPIPERIDINES | Search 4+ANILIDOPIPERIDINES |
4 | MM2 87 | 2 | 67% | 1% | 2 | Search MM2+87 | Search MM2+87 |
5 | LIGAND MODEL | 1 | 100% | 1% | 2 | Search LIGAND+MODEL | Search LIGAND+MODEL |
6 | OPIOID LIGAND MODEL | 1 | 100% | 1% | 2 | Search OPIOID+LIGAND+MODEL | Search OPIOID+LIGAND+MODEL |
7 | 3D STRUCTURE ACTIVITY RELATIONSHIP | 1 | 50% | 0% | 1 | Search 3D+STRUCTURE+ACTIVITY+RELATIONSHIP | Search 3D+STRUCTURE+ACTIVITY+RELATIONSHIP |
8 | CONFORMATIONAL PROFILE | 1 | 50% | 0% | 1 | Search CONFORMATIONAL+PROFILE | Search CONFORMATIONAL+PROFILE |
9 | DIAZABICYCLOOCTANE | 1 | 50% | 0% | 1 | Search DIAZABICYCLOOCTANE | Search DIAZABICYCLOOCTANE |
10 | METAL ADSORPTION ABILITY | 1 | 50% | 0% | 1 | Search METAL+ADSORPTION+ABILITY | Search METAL+ADSORPTION+ABILITY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SYNTHETIC ANALGESICS | 27 | 92% | 4% | 11 |
2 | 4 ANILIDOPIPERIDINE ANALGESICS | 11 | 78% | 2% | 7 |
3 | OHMEFENTANYL | 8 | 70% | 2% | 7 |
4 | CIS 3 METHYLFENTANYL | 4 | 75% | 1% | 3 |
5 | FENTANYL ANALOGS | 3 | 50% | 1% | 4 |
6 | POTENT ANALGESICS | 2 | 67% | 1% | 2 |
7 | BICYCLIC HOMOLOGS | 2 | 43% | 1% | 3 |
8 | DIRECTED ACYLATING AGENT | 2 | 43% | 1% | 3 |
9 | 1 SUBSTITUTED 4 PROPANANILIDOPERHYDROAZEPINES | 1 | 100% | 1% | 2 |
10 | REVERSED ESTERS | 1 | 100% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications | 2014 | 4 | 111 | 41% |
Fentanyl Analogs: Structure-Activity-Relationship Study | 2009 | 6 | 47 | 49% |
Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor | 2000 | 50 | 78 | 32% |
Potential Chemical Warfare Agents | 2011 | 0 | 1 | 100% |
Molecular modeling of fentanyl analogs | 2004 | 3 | 31 | 35% |
ONE-RECEPTOR AND 2-RECEPTOR MODELS OF OPIOID DRUG-ACTION | 1985 | 2 | 1 | 100% |
OPIATE STRUCTURE AND ACTIVITY - A GUIDE TO UNDERSTANDING THE RECEPTOR | 1984 | 37 | 8 | 13% |
Drugs in anesthetic practice | 1996 | 13 | 43 | 7% |
NEUROPHARMACOLOGICAL ACTIVITY OF PIPERIDINE-DERIVATIVES (A REVIEW) | 1991 | 2 | 66 | 11% |
EXPERIMENTAL-THERAPY OF ADJUVANT DISEASE | 1983 | 0 | 5 | 40% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | USTAV OCHRANY PROTI ZBRANIM HROMADNEHO NICENI | 2 | 67% | 0.7% | 2 |
2 | VMRF | 1 | 50% | 0.3% | 1 |
3 | DIPARTIMENTO CHIM FARMACEUT TOXXICOL | 0 | 33% | 0.3% | 1 |
4 | NEUROSCI SCARL | 0 | 33% | 0.3% | 1 |
5 | ABX ADV BIOCHEM CPDS | 0 | 17% | 0.3% | 1 |
6 | HIGH RISK PREGNANCIES | 0 | 17% | 0.3% | 1 |
7 | AARUPADAI VEEDU TECHNOL | 0 | 10% | 0.3% | 1 |
8 | GUANGHZOU CHEM | 0 | 100% | 0.3% | 1 |
9 | INTERAMURAL | 0 | 100% | 0.3% | 1 |
10 | INVEST MAT CIUDAD UNIV | 0 | 100% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000151726 | DYNORPHIN//CI 977//DYNORPHIN A |
2 | 0.0000140715 | DELTA OPIOID RECEPTOR//DELTA OPIOID AGONIST//SNC80 |
3 | 0.0000132028 | DIETHER LINKED//PROPRANOLOL ANALOG//BETA ADRENERGIC AGENT |
4 | 0.0000117126 | NORFENTANYL//MUSCULAR RIGIDITY//SUFENTANIL |
5 | 0.0000085667 | TETRADECAHYDROACRIDINES//SATURATED AMINE OXIDES//TETRADECAHYDRO |
6 | 0.0000075815 | TARTRAMIDES//CARBONYL CARBONYL INTERACTIONS//R R TARTARIC ACID DERIVATIVES |
7 | 0.0000075192 | MU OPIOID RECEPTOR//OPIOID RECEPTOR//MOR 1 |
8 | 0.0000073419 | 3RD MESSENGER//LEARNED HELPLESSNESS BEHAVIOR//MARKER ENZYME |
9 | 0.0000069064 | CHEM BIOL PEPTIDE//ENDOMORPHIN 2//ENDOMORPHIN |
10 | 0.0000063638 | NEFOPAM//ORPHENADRINE//ANALGESICS NON OPIOID NEFOPAM |